Fish oil attenuates neurologic severity of antiphospholipid syndrome in a mice experimental model

References

• Asherson RA, Piette JC. The catastrophic antiphospholipid syndrome 1996: acute multi-organ failure associated with antiphospholipid antibodies: a review of 31 patients. Lupus 1996;5:414–7. doi: 10.1177/096120339600500516
   PubMed Web of Science ®Google Scholar
• Hughes GR. The antiphospholipid syndrome: ten years on. Lancet 1993;342:341–4. doi: 10.1016/0140-6736(93)91477-4
   PubMed Web of Science ®Google Scholar
• Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999 Jul;42(7):1309–11. doi: 10.1002/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F
   PubMed Web of Science ®Google Scholar
• Brey RL. Differential diagnosis of central nervous system manifestations of the antiphospholipid antibody syndrome. J Autoimmun 2000;15:133–8. doi: 10.1006/jaut.2000.0426
   PubMed Web of Science ®Google Scholar
• Hojnik M, George J, Ziporen L, Shoenfeld Y. Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome. Circulation 1996;93:1579–87. doi: 10.1161/01.CIR.93.8.1579
   PubMed Web of Science ®Google Scholar
• Levy Y, Ziporen L, Gilburd B, George J, Polak-Charcon S, Amital H, et al. Membranous nephropathy in primary antiphospholipid syndrome: description of a case and induction of renal injury in SCID mice. Hum Antibodies Hybridomas. 1996;7(3):91–6.
   PubMedGoogle Scholar
• Ziporen L, Goldberg I, Arad M, Hojnik M, Ordi-Ros J, Afek A, et al. Libman-Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves. Lupus 1996 Jun;5(3):196–205. doi: 10.1177/096120339600500306
   PubMed Web of Science ®Google Scholar
• Muscal E, Brey RL. Neurologic manifestations of the antiphospholipid syndrome: integrating molecular and clinical lessons. Curr Rheumatol Rep 2008;10:67–73. doi: 10.1007/s11926-008-0012-y
   PubMedGoogle Scholar
• Tektonidou MG, Varsou N, Kotoulas G, Antoniou A, Moutsopoulos HM. Cognitive deficits in patients with antiphospholipid syndrome: association with clinical, laboratory, and brain magnetic resonance imaging findings. Arch Intern Med 2006;166:2278–84. doi: 10.1001/archinte.166.20.2278
   PubMedGoogle Scholar
• Toubi E, Khamashta MA, Panarra A, Hughes GR. Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus. Am J Med 1995;99:397–401. doi: 10.1016/S0002-9343(99)80188-0
   PubMed Web of Science ®Google Scholar
• Cuadrado MJ, Khamashta MA, Ballesteros A, Godfrey T, Simon MJ, Hughes GR. Can neurologic manifestations of Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature. Medicine (Baltimore) 2000;79:57–68. doi: 10.1097/00005792-200001000-00006
   PubMed Web of Science ®Google Scholar
• Theodoridou A, Settas L. Demyelination in rheumatic diseases. J Neurol Neurosurg Psychiatry 2006;77:290–5.
   PubMed Web of Science ®Google Scholar
• Schwartz M, Rochas M, Weller B, Sheinkman A, Tal I, Golan D, et al. High association of anticardiolipin antibodies with psychosis. J Clin Psychiatry 1998;59:20–23. doi: 10.4088/JCP.v59n0105
   PubMed Web of Science ®Google Scholar
• Sun KH, Liu WT, Tsai CY, Liao TS, Lin WM, Yu CL. Inhibition of astrocyte proliferation and binding to brain tissue of anticardiolipin antibodies purified from lupus serum. Ann Rheum Dis 1992;51:707–12. doi: 10.1136/ard.51.6.707
   PubMed Web of Science ®Google Scholar
• Vargas-Hitos JA, Ateka-Barrutia O, Sangle S, Khamashta MA. Efficacy and safety of long-term low molecular weight heparin in patients with antiphospholipid syndrome. Ann Rheum Dis 2011;70:1652–4. doi: 10.1136/ard.2011.150268
   PubMed Web of Science ®Google Scholar
• Roubey RA. New approaches to prevention of thrombosis in the antiphospholipid syndrome: hopes, trials, and tribulations. Arthritis Rheum 2003;48:3004–8. doi: 10.1002/art.11332
   PubMed Web of Science ®Google Scholar
• Chapman J, Rand JH, Brey RL, Levine SR, Blatt I, Khamashta MA, et al. Non-stroke neurological syndromes associated with antiphospholipid antibodies: evaluation of clinical and experimental studies. Lupus 2003;12(7):514–7. doi: 10.1191/0961203303lu392oa
   PubMed Web of Science ®Google Scholar
• Tanne D, Katzav A, Beilin O, Grigoriadis NC, Blank M, Pick CG, et al. Interaction of inflammation, thrombosis, aspirin and enoxaparin in CNS experimental antiphospholipid syndrome. Neurobiol Dis 2008 Apr;30(1):56–64. doi: 10.1016/j.nbd.2007.12.004
   PubMed Web of Science ®Google Scholar
• Carta G, Iovenitti P, Falciglia K. Recurrent miscarriage associated with antiphospholipid antibodies: prophylactic treatment with low-dose aspirin and fish oil derivatives. Clin Exp Obstet Gynecol 2005;32:49–51.
   PubMedGoogle Scholar
• Rossi E, Costa M. Fish oil derivatives as a prophylaxis of recurrent miscarriage associated with antiphospholipid antibodies (APL): a pilot study. Lupus 1993;2:319–23. doi: 10.1177/096120339300200508
   PubMed Web of Science ®Google Scholar
• Leiba A, Amital H, Gershwin ME, Shoenfeld Y. Diet and lupus. Lupus 2001;10:246–8. doi: 10.1191/096120301674681790
   PubMed Web of Science ®Google Scholar
• Ruxton CH, Calder PC, Reed SC, Simpson MJ. The impact of long-chain n-3 polyunsaturated fatty acids on human health. Nutr Res Rev 2005;18:113–29. doi: 10.1079/NRR200497
   PubMed Web of Science ®Google Scholar
• Motterlini R, Foresti R, Bassi R, Green CJ. Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress. Free Radic Biol Med 2000;28:1303–12. doi: 10.1016/S0891-5849(00)00294-X
   PubMed Web of Science ®Google Scholar
• Sun AY, Wang Q, Simonyi A, Sun GY. Botanical phenolics and brain health. Neuromolecular Med 2008;10:259–74. doi: 10.1007/s12017-008-8052-z
   PubMed Web of Science ®Google Scholar
• Khajehdehi P, Zanjaninejad B, Aflaki E, Nazarinia M, Azad F, Malekmakan L, et al. Oral supplementation of turmeric decreases proteinuria, hematuria, and systolic blood pressure in patients suffering from relapsing or refractory lupus nephritis: a randomized and placebo-controlled study. J Ren Nutr 2012 Jan;22(1):50–7. doi: 10.1053/j.jrn.2011.03.002
   PubMed Web of Science ®Google Scholar
• Kurien BT, D'Souza A, Scofield RH. Heat-solubilized curry spice curcumin inhibits antibody-antigen interaction in in vitro studies: a possible therapy to alleviate autoimmune disorders. Mol Nutr Food Res 2010;54:1202–9.
   PubMed Web of Science ®Google Scholar
• Natarajan C, Bright JJ. Curcumin inhibits experimental allergic encephalomyelitis by blocking IL-12 signaling through Janus kinase-STAT pathway in T lymphocytes. J Immunol 2002;168:6506–13. doi: 10.4049/jimmunol.168.12.6506
   PubMed Web of Science ®Google Scholar
• Bakimer R, Fishman P, Blank M, Sredni B, Djaldetti M, Shoenfeld Y. Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3). J Clin Invest 1992;89:1558–63. doi: 10.1172/JCI115749
   PubMed Web of Science ®Google Scholar
• Katzav A, Pick CG, Korczyn AD, Oest E, Blank M, Shoenfeld Y, et al. Hyperactivity in a mouse model of the antiphospholipid syndrome. Lupus 2001;10(7):496–9. doi: 10.1191/096120301678416060
   PubMed Web of Science ®Google Scholar
• McNeil HP, Simpson RJ, Chesterman CN, Krilis SA. Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 1990;87:4120–4. doi: 10.1073/pnas.87.11.4120
   PubMed Web of Science ®Google Scholar
• Shrot S, Katzav A, Korczyn AD, Litvinju Y, Hershenson R, Pick et al. Behavioral and cognitive deficits occur only after prolonged exposure of mice to antiphospholipid antibodies. Lupus 2002;11(11):736–43. doi: 10.1191/0961203302lu255oa
   Web of Science ®Google Scholar
• Ziporen L, Shoenfeld Y, Levy Y, Korczyn AD. Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies. A mouse model. J Clin Invest 1997;100:613–9. doi: 10.1172/JCI119572
   PubMed Web of Science ®Google Scholar
• Ziporen L, Polak-Charcon S, Korczyn DA, Goldberg I, Afek A, Kopolovic J, et al. Neurological dysfunction associated with antiphospholipid syndrome: histopathological brain findings of thrombotic changes in a mouse model. Clin Dev Immunol 2004 Mar;11(1):67–75. doi: 10.1080/10446670410001670526
   PubMedGoogle Scholar
• Xie W, Zhang Y, Bu C, Sun S, Hu S, Cai G. Anti-coagulation effect of Fc fragment against anti-beta2-GP1 antibodies in mouse models with APS. Int Immunopharmacol 2011;11:136–40. doi: 10.1016/j.intimp.2010.10.018
   PubMed Web of Science ®Google Scholar
• Cervera R, Boffa MC, Khamashta MA, Hughes GR. The Euro-Phospholipid project: epidemiology of the antiphospholipid syndrome in Europe. Lupus 2009;18:889–93. doi: 10.1177/0961203309106832
   PubMed Web of Science ®Google Scholar
• Frances C, Papo T, Wechsler B, Laporte JL, Biousse V, Piette JC. Sneddon syndrome with or without antiphospholipid antibodies. A comparative study in 46 patients. Medicine (Baltimore) 1999;78:209–19. doi: 10.1097/00005792-199907000-00001
   PubMed Web of Science ®Google Scholar
• Andriamampandry MD, Leray C, Freund M, Cazenave JP, Gachet C. Antithrombotic effects of (n-3) polyunsaturated fatty acids in rat models of arterial and venous thrombosis. Thromb Res 1999;93:9–16. doi: 10.1016/S0049-3848(98)00149-2
   PubMed Web of Science ®Google Scholar
• Kuma H, Nagashima R, Hatae H, Tsuda T, Hamasaki N. Beneficial effect of EPA (20:5 n-3 PUFA) on preventing venous thromboembolism: a rat tail thrombosis model experiment. Thromb Res 2013;131:107–8. doi: 10.1016/j.thromres.2012.09.014
   PubMed Web of Science ®Google Scholar
• Berger A, German JB, Gershwin ME. Implications of modifying cardiolipin acyl composition by diet. 1. Cardiolipin acyl chain is an important determinant in the binding to antiphospholipid antibodies in SLE sera. J Autoimmun 1992;5:229–41. doi: 10.1016/0896-8411(92)90202-2
   PubMed Web of Science ®Google Scholar
• Hess DC, Sethi K, Awad E. Thrombotic thrombocytopenic purpura in systemic lupus erythematosus and antiphospholipid antibodies: effective treatment with plasma exchange and immunosuppression. J Rheumatol 1992;19:1474–8.
   PubMed Web of Science ®Google Scholar
• Smith HR, Hansen CL, Rose R, Canoso RT. Autoimmune MRL-1 pr/1pr mice are an animal model for the secondary antiphospholipid syndrome. J Rheumatol 1990;17:911–5.
   PubMed Web of Science ®Google Scholar
• Foxley S, Zamora M, Hack B, Alexander RR, Roman B, Quigg RJ, et al. Curcumin aggravates CNS pathology in experimental systemic lupus erythematosus. Brain Res. 2013 Apr 4;1504:85–96. doi: 10.1016/j.brainres.2013.01.040
   PubMed Web of Science ®Google Scholar
• Sofroniew MV, Vinters HV. Astrocytes: biology and pathology. Acta Neuropathol 2010;119:7–35. doi: 10.1007/s00401-009-0619-8
   PubMed Web of Science ®Google Scholar
• Caronti B, Calderaro C, Alessandri C, Conti F, Tinghino R, Palladini G, et al. Beta2-glycoprotein I (beta2-GPI) mRNA is expressed by several cell types involved in anti-phospholipid syndrome-related tissue damage. Clin Exp Immunol 1999 Jan;115(1):214–9. doi: 10.1046/j.1365-2249.1999.00770.x
   PubMed Web of Science ®Google Scholar
• Caronti B, Pittoni V, Palladini G, Valesini G. Anti-beta 2-glycoprotein I antibodies bind to central nervous system. J Neurol Sci 1998;156:211–9. doi: 10.1016/S0022-510X(98)00027-6
   PubMed Web of Science ®Google Scholar
• Orr SK, Bazinet RP. The emerging role of docosahexaenoic acid in neuroinflammation. Curr Opin Investig Drugs 2008;9:735–43.
   PubMedGoogle Scholar
• Orr SK, Trepanier MO, Bazinet RP. n-3 Polyunsaturated fatty acids in animal models with neuroinflammation. Prostaglandins Leukot Essent Fatty Acids 2013;88:97–103. doi: 10.1016/j.plefa.2012.05.008
   PubMed Web of Science ®Google Scholar
• Sergeeva M, Strokin M, Wang H, Ubl JJ, Reiser G. Arachidonic acid and docosahexaenoic acid suppress thrombin-evoked Ca2+ response in rat astrocytes by endogenous arachidonic acid liberation. J Neurochem 2002;82:1252–61. doi: 10.1046/j.1471-4159.2002.01052.x
   PubMed Web of Science ®Google Scholar
• Pan HC, Kao TK, Ou YC, Yang DY, Yen YJ, Wang CC, et al. Protective effect of docosahexaenoic acid against brain injury in ischemic rats. J Nutr Biochem 2009 Sep;20(9):715–25. doi: 10.1016/j.jnutbio.2008.06.014
   PubMed Web of Science ®Google Scholar
• Shinto L, Marracci G, Bumgarner L, Yadav V. The effects of omega-3 Fatty acids on matrix metalloproteinase-9 production and cell migration in human immune cells: implications for multiple sclerosis. Autoimmune Dis 2011;2011:134592.
   PubMedGoogle Scholar